International clinical trial to test the use of dye during children’s cancer surgery
Testing whether a dye called Indocyanine Green (ICG) can help surgeons identify tumours and lymph nodes during surgery.
We have been funding expert research since 2016, aiming to ensure that every child and young person has a safe and effective treatment for their cancer, and that they can live long and happy lives post-treatment.
Testing whether a dye called Indocyanine Green (ICG) can help surgeons identify tumours and lymph nodes during surgery.
Testing the use of green dye in surgery to remove kidney tumours.
Investigating how antibody immunotherapy causes pain and nerve damage.
Using a new way to measure genetic variation in key sections of noncoding DNA.
Finding which MEK inhibitors work best for children with acute myeloid leukaemia.
Stopping protein activity to stop anaplastic large cell lymphomas from growing.
Looking at molecular makeup and MRIs to characterise infant ependymoma.
Testing nanoparticles as a way of getting drugs where they are needed for acute myeloid leukaemia.
Understanding how proteins act inside acute myeloid leukaemia cells, to find new drug targets.